CVE:ZMD - ZoomMed Stock Price, News & Analysis

Today's Range N/A
50-Day Range
C$0.02
MA: C$0.02
C$0.02
52-Week Range N/A
VolumeN/A
Average Volume290,486 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
ZoomMed Inc., together with its subsidiaries, develops and markets a range of computer applications designed for healthcare professionals primarily in the United States and the United Kingdom. The company builds and operates a clinical information exchange platform between physicians, pharmacists, and various other stakeholders of the healthcare sector, such as pharmacists, specialists, pharmaceutical companies, laboratories, physiotherapy clinics, and other organizations. It also offers ZRx Prescriber, a technological Web application that enables physicians to generate prescriptions. ZoomMed Inc. was incorporated in 2005 and is headquartered in Brossard, Canada.

Industry, Sector and Symbol

Industry Health Information Services
Sub-IndustryN/A
SectorComputer and Technology
CUSIPN/A
CIKN/A
Phone+1-450-6785457

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$10,000.00
Book ValueC($0.02) per share

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive ZMD News and Ratings via Email

Sign-up to receive the latest news and ratings for ZMD and its competitors with MarketBeat's FREE daily newsletter.


ZoomMed (CVE:ZMD) Frequently Asked Questions

What is ZoomMed's stock symbol?

ZoomMed trades on the Canadian Venture Exchange (CVE) under the ticker symbol "ZMD."

Has ZoomMed been receiving favorable news coverage?

Media stories about ZMD stock have been trending negative on Tuesday, according to InfoTrie. The research group identifies negative and positive news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. ZoomMed earned a media sentiment score of -2.9 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the company's share price in the near future. View News Stories for ZoomMed.

Who are some of ZoomMed's key competitors?

Who are ZoomMed's key executives?

ZoomMed's management team includes the folowing people:
  • Mr. Yves Marmet, Chairman, CEO & Pres
  • Ms. Marie-Helene Pinard, CFO, VP of Operations & Fin., Sec. and Director
  • Mr. André Marmet, VP of Corp. Bus.

How do I buy shares of ZoomMed?

Shares of ZMD and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is ZoomMed's official website?

The official website for ZoomMed is http://zoommedcorpo.com/.

How can I contact ZoomMed?

ZoomMed's mailing address is 8005 du Quartier Blvd Suite 303, BROSSARD, QC J4Y 0N5, Canada. The company can be reached via phone at +1-450-6785457.


MarketBeat Community Rating for ZoomMed (CVE ZMD)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  40 (Vote Outperform)
Underperform Votes:  51 (Vote Underperform)
Total Votes:  91
MarketBeat's community ratings are surveys of what our community members think about ZoomMed and other stocks. Vote "Outperform" if you believe ZMD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ZMD will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel